Neirg Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Neirg Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $1,783 - $1,980	-28 Reduced 0.59%	4,747 $303,000
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $46,391 - $52,618	706 Added 17.35%	4,775 $330,000
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $50 - $29,660	-386 Reduced 8.66%	4,069 $289,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $65,648 - $72,301	904 Added 25.46%	4,455 $343,000
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $6,148 - $7,372	100 Added 2.9%	3,551 $259,000
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $185,077 - $215,756	3,451 New	3,451 $215,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Neirg Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Neirg Wealth Management, LLC with notifications on news.